{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:42:10Z","timestamp":1792636930680,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:sec id=\"ab-doi230001-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Alopecia areata (AA) is characterized by nonscarring hair loss of the scalp, face, and\/or body. Alopecia totalis (AT) and alopecia universalis (AU) involve complete loss of the scalp and body hair, respectively. The epidemiology of AA in the US remains unclear, having previously been extrapolated from older studies that were limited to specific geographic areas or clinical settings, or from self-reported data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the annual prevalence and incidence of AA and AT and\/or AU (AT\/AU) in the US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective, population-based cohort study was conducted from January 2016 to December 2019 and included enrollees in the IBM MarketScan Commercial Claims and Encounters and Medicare Supplemental databases and their dependents, with plan enrollment during each study calendar year and the year prior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>\n                      Prevalent cases were identified by 1 or more claims for AA or AT\/AU (\n                      <jats:italic>International Statistical Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM]<\/jats:italic>\n                      codes L63.x, L63.0, L63.1) during each year of interest or the year prior. Incident cases were identified by 1 or more claims for AA or AT\/AU during a specific year and no diagnosis the year prior.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Annual incidence and prevalence rates were calculated and stratified by age, sex, and region. National employer-sponsored insurance population estimates were obtained using population-based weights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among eligible patients (2016: n\u2009=\u200918\u202f368 [mean (SD) age, 40.6 (17.9) years; 12\u202f295 women (66.9%)]; 2017: n\u2009=\u200914\u202f372 [mean (SD) age, 39.6 (17.7) years; 9195 women (64.0%)]; 2018: n\u2009=\u200914\u202f231 [mean (SD) age, 38.9 (17.3) years; 8998 women (63.2%)]; 2019: n\u2009=\u200913\u202f455 [mean (SD) age, 39.1 (17.4) years; 8322 women (61.9%)]), AA prevalence increased from 0.199% (95% CI, 0.198%-0.200%) in 2016 to 0.222% (95% CI, 0.221%-0.223%) in 2019. Roughly 5% to 10% of prevalent and incident cases of AA were AT\/AU. The prevalence of AT\/AU increased from 0.012% (95% CI, 0.012%-0.013%) to 0.019% (95% CI, 0.018%-0.019%) from 2016 to 2019. Incidence of AA per 100\u202f000 person-years ranged from 87.39 (95% CI, 86.84-87.96) in 2017 to 92.90 (95% CI, 92.35-93.45) in 2019. Incidence of AT\/AU ranged from 7.09 (95% CI, 6.94-7.25) in 2017 to 8.92 (95% CI, 8.75-9.09) in 2016. Prevalence and incidence of AA and AT\/AU were higher among female vs male individuals, adults vs children and adolescents, and in the Northeast vs other regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi230001-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The results of this cohort study suggest that these recent AA prevalence and incidence estimates could help improve current understanding of the disease burden. Further research is warranted to elucidate subpopulation differences and trends in AA in the broader US population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2023.0002","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T11:01:19Z","timestamp":1677668479000},"page":"411","source":"Crossref","is-referenced-by-count":97,"title":["Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population"],"prefix":"10.1001","volume":"159","author":[{"given":"Arash","family":"Mostaghimi","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Analysis Group Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markqayne","family":"Ray","sequence":"additional","affiliation":[{"name":"Pfizer Inc, Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Bartolome","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Wang","sequence":"additional","affiliation":[{"name":"Analysis Group Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Carley","sequence":"additional","affiliation":[{"name":"Analysis Group Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Done","sequence":"additional","affiliation":[{"name":"Analysis Group Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Swallow","sequence":"additional","affiliation":[{"name":"Analysis Group Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi230001r1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.1997.9.issue-1","article-title":"The genetic epidemiology and autoimmune pathogenesis of alopecia areata.","volume":"9","author":"McMichael","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi230001r2","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: a systematic review.","volume":"8","author":"Villasante Fricke","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"doi230001r3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2340\/0001555549180188","article-title":"Alopecia areata: a follow-up investigation of outpatient material.","volume":"49","author":"Gip","year":"1969","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"doi230001r4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/jid.1950.52","article-title":"A statistical study and consideration of endocrine influences.","volume":"14","author":"Walker","year":"1950","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi230001r5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989.","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"doi230001r6","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata.","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"doi230001r7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients.","volume":"55","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi230001r8","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/jidsymp.2013.18","article-title":"Health-related quality of life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.","volume":"16","author":"Shi","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"doi230001r9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaad.2018.01.048","article-title":"Alopecia areata is associated with impaired health-related quality of life: a survey of affected adults and children and their families.","volume":"79","author":"Liu","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi230001r10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis.","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi230001r11","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","article-title":"Burden of illness in alopecia areata: a cross-sectional online survey study.","volume":"20","author":"Mesinkovska","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"9","key":"doi230001r12","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","article-title":"Alopecia areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims.","volume":"38","author":"Senna","year":"2021","journal-title":"Adv Ther"},{"issue":"4","key":"doi230001r13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamadermatol.2018.5218","article-title":"Association of out-of-pocket health care costs and financial burden for patients with alopecia areata.","volume":"155","author":"Li","year":"2019","journal-title":"JAMA Dermatol"},{"key":"doi230001r14","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.1016\/j.jval.2019.04.1853","article-title":"PSY29 economic burden of alopecia areata in a US managed care population.","volume":"22","author":"Xenakis","year":"2019","journal-title":"Value Health"},{"issue":"4","key":"doi230001r15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.18553\/jmcp.2022.28.4.426","article-title":"All-cause health care resource utilization and costs among adults with alopecia areata: a retrospective claims database study in the United States.","volume":"28","author":"Mostaghimi","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"doi230001r16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009.","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"5","key":"doi230001r17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1001\/archderm.1992.01680150136027","article-title":"Prevalence of alopecia areata in the first National Health and Nutrition Examination Survey.","volume":"128","author":"Safavi","year":"1992","journal-title":"Arch Dermatol"},{"issue":"2","key":"doi230001r18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata.","volume":"46","author":"Wasserman","year":"2007","journal-title":"Int J Dermatol"},{"issue":"5","key":"doi230001r19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaad.2017.06.035","article-title":"Prevalence of pediatric alopecia areata among 572,617 dermatology patients.","volume":"77","author":"Caldwell","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"doi230001r21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CCID.S245649","article-title":"A large cross-sectional survey study of the prevalence of alopecia areata in the United States.","volume":"13","author":"Benigno","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"doi230001r22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis.","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi230001r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis.","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"doi230001r24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"doi230001r25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/ijt.ijt_67_20","article-title":"Validation of case identification for alopecia areata using international classification of diseases coding.","volume":"12","author":"Lavian","year":"2020","journal-title":"Int J Trichology"},{"issue":"3","key":"doi230001r27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/jssam\/smy019","article-title":"Comparative study of confidence intervals for proportions in complex sample surveys.","volume":"7","author":"Franco","year":"2019","journal-title":"J Surv Stat Methodol"},{"issue":"6","key":"doi230001r28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"6","key":"doi230001r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196517","article-title":"Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO).","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"doi230001r30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40257-018-0405-2","article-title":"The medical and psychosocial associations of alopecia: recognizing hair loss as more than a cosmetic concern.","volume":"20","author":"Marks","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"doi230001r31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ddg.2015.13.issue-2","article-title":"Quality of life and psychosocial impact of scarring and non-scarring alopecia in women.","volume":"13","author":"Katoulis","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"doi230001r32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","article-title":"Alopecia areata: an evaluation of 736 patients.","volume":"88","author":"Muller","year":"1963","journal-title":"Arch Dermatol"},{"issue":"2","key":"doi230001r33","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jaad.2006.02.045","article-title":"Alopecia in the United States: outpatient utilization and common prescribing patterns.","volume":"57","author":"McMichael","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"doi230001r34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archdermatol.2010.127","article-title":"Trends in dermatology: geographic density of US dermatologists.","volume":"146","author":"Yoo","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"doi230001r35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jamadermatol.2022.0351","article-title":"Evaluation of the prevalence and incidence of pediatric alopecia areata using electronic health record data.","volume":"158","author":"McKenzie","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi230001r36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-0038-1673354","article-title":"Truven Health Analytics MarketScan databases for clinical research in colon and rectal surgery.","volume":"32","author":"Kulaylat","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"issue":"1","key":"doi230001r37","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata.","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"doi230001r20","first-page":"2919","volume-title":"Rook\/Wilkinson\/Ebling Textbook of Dermatology","author":"Dawber","year":"1998"},{"key":"doi230001r26","unstructured":"US Census Bureau. Data from 2009-2011 American Community Survey 3-year public use microdata samples. Accessed January 15, 2021. https:\/\/www.census.gov\/programs-surveys\/acs\/microdata.html"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2801705\/jamadermatology_mostaghimi_2023_oi_230001_1681833178.43953.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T21:22:49Z","timestamp":1701984169000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2801705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.0002","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}